Author

Amandine M.F. Rovini

InsermORCID 0000-0003-0483-9092Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:differential expression· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Fabrice LallouéiD· 2 shared Alain ChaunaveliD· 1 shared Amy GateauiD· 1 shared Anaëlle ChermatiD· 1 shared Arnaud PothieriD· 1 shared Charlotte JemferiD· 1 shared Claire Dalmay AiD· 1 shared Héloïse DaveratiD· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Fabrice LallouéORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologyCancer Cell InternationalPeer-reviewedApr 1, 2026

New proteomic signature in circulating extracellular vesicles from tumor-draining vein of lung adenocarcinomas patients

Jérémy Tricard, Stéphanie Durand, Amandine M.F. Rovini…·Fabrice Lalloué

The paper identifies a proteomic signature in extracellular vesicles from tumor-draining veins of NSCLC patients that may serve as prognostic biomarkers for relapse.

2 citations

humanproteomics

𝕏 PostBluesky

Cancer BiologybioRxivPreprintNov 5, 2024

Predicting Tumor Mutational Burden from UHF-Dielectrophoresis Crossover Frequency

Héloïse Daverat, Nina Blasco, Sandrine Robert…·Thomas Naves

This paper proposes using UHF-dielectrophoresis crossover frequency (EMS) to predict tumor mutational burden (TMB) as a rapid, low-cost alternative to whole exome sequencing.

1 citation

experimental assay

𝕏 PostBluesky